Overview

A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA)

Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
This is a safety and efficacy study of bimatoprost in male subjects with androgenic alopecia (AGA).
Phase:
Phase 2
Details
Lead Sponsor:
Allergan
Treatments:
Bimatoprost
Pharmaceutical Solutions